Drawing for HEMOCLEAR

USPTO serial 86918947

HEMOCLEAR

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
YOO, JEANE
Law office
TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with HEMOCLEAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael C. Cerrati

Michael C. Cerrati BELZER PC2905 Bull StreetSavannah, GA 31405UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical and surgical apparatus, instruments and devices for taking blood, collecting blood, pumping blood, blood component separation, filtering blood, testing blood and blood analysis; Blood transfusion apparatus; Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Blood storage bags for medical purposes; Blood tubing sets for medical purposes; Needles for medical use; Syringes for medical purposes; autologous blood processing apparatus and instruments, namely, blood filters; autologous blood recovery apparatus, namely, blood collection bags for medical purposes; blood processing equipment for medical use, namely, apparatus for the autologous recovery of blood; blood taking and transfusion apparatus, namely, blood recovery device used for taking, drawing, collecting and rein fusing autologous blood for medical purposes, sold empty; autologous blood transfusion devicesACTIVE—
035mediation of trade business for third parties in connection with wholesale and retail services in the field of the purchase and sale, import and export of surgical and medical apparatus, instruments and devices for taking, collecting, separating, filtering, pumping, testing and analyzing blood, autologous blood processing apparatus and instruments, autologous blood recovery apparatus, autologous blood filters, blood pumps, bags for collecting and storing blood, tubes, pumps, needles and push syringes for medical use and parts of the aforesaid goods; organization of trade fairs and exhibitions for business and advertising purposes; consulting services in the field of medical and surgical apparatus, instruments and devices; providing information online in the fields of medical and surgical apparatus, instruments and devicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 6, 2017MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 6, 2017ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 20, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 19, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 8, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2016DOCKASSIGNED TO EXAMINER—
Mar 1, 2016MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 29, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 27, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance